Skip to Search
Skip to Navigation
Skip to Main Content
Skip to Footer
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Login
Google Translate
Select language
English
French
Spanish
Login
Username
*
Password
*
Staff Login
×
Google Translate
Select language
English
French
Spanish
Login
Menu
Site Search
Search Options
Resources
Everything
Advanced Search
Uptodate
All
Title Search
Author
Patients & Caregivers
Healthcare Providers
Researchers & Partners
Investors
menu
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Google News
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Sage Therapeutics, Inc. (SAGE) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Sage Therapeutics, Inc. (SAGE) Reports Q4 Loss, Lags Revenue Estimates - Nasdaq
Sage Therapeutics Inc. (SAGE) reports earnings - Quartz
SAGE Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary - TradingView
SAGE Therapeutics earnings missed by $0.06, revenue fell short of estimates - Investing.com
Bronstein, Gewirtz & Grossman, LLC Encourages Sage Therapeutics, Inc. (SAGE) Shareholders to Inquire about Securities Investigation - Markets Insider
SAGE Therapeutics (SAGE) Misses Q4 EPS by 6c - StreetInsider.com
Sage Therapeutics, Inc. SEC 10-K Report - TradingView
Sage Therapeutics Q4 and Full Year 2024 Financial Results - TradingView
Sage's Postpartum Depression Drug Hits Record Sales: Q4 Revenue and Market Coverage Surge - StockTitan
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »
×